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1. Introduction 
We have recently described a cytochrome b in 
human neutrophils [ 11. It is located predominantly 
within the plasma membrane [2,3] and is rapidly 
incorporated into the phagocytic vacuole [ 1,3]. We 
believe that the microbicidal oxidase system of 
neutrophils contains an electron transport chain in 
which this cytochrome b is a central component. The 
evidence for the involvement of this cytochrome b 
in the oxidase system is 2-fold. Stimulation of neutro- 
phils with phorbol myristate acetate (PMA) activates 
the oxidase system [4] and results in the reduction 
and subsequent oxidation of this cytochrome b [5]. 
This cytochrome b was not found in reduced- 
oxidised spectra of neutrophils from a group of 
patients with Chronic Granulomatous Disease (CGD) 
[6], a syndrome in which a predisposition to bacterial 
infection is associated with the absence of demon- 
strable oxidase activity in their neutrophils upon 
stimulation [7]. However, this cytochrome b was 
later found in some patients with CGD, particularly 
those with an autosomal mode of inheritance [8,9]. 
This study was conducted to investigate whether 
neutrophils from patients with CGD, both those with 
and those without spectroscopic evidence of the 
cytochrome b, demonstrate the normal pattern of 
reduction of this cytochrome after stimulation of the 
cells with PMA. It was found that the cytochrome b 
was not reduced in any of these patients. This strongly 
implicates this electron transport chain in the micro- 
bicidal oxidase system. It also confirms that the syn- 
drome of CGD is the result of at least two different 
molecular aberrations; in some cases the cytochrome b 
is missing, in others it fails to become reduced upon 
stimulation of the cell, either because of the absence 
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of a proximal component of the electron transport 
chain or because of the failure of some activation 
mechanism. 
2. Patients, materials and methods 
2.1. Patients 
Four patients with CGD were studied. Patient 1 
was a 30 year old female. There was no history of 
illnesses in her parents or 3 month old child. Patients 
2-4, were a female and two males (respectively, 
patients U, Q and G in [6]). The diagnosis of CGD 
was confirmed in all these patients on the basis of a 
clinical history of pyogenic infection [7], defective 
killing of Staphylococci [lo] impaired reduction of 
nitroblue-tetrazolium [ 1 l] by their neutrophils, and 
absence of the normal enhancement of oxygen con- 
sumption after stimulation of these cells with IgG 
opsonised latex particles [ 121 and PMA [4]. Informed 
consent was obtained from all the subjects. 
2.2. Isolation of neutrophils 
Venous blood (100 ml from patients l-3 and 4 
normal healthy controls, 50 ml from patient 4) was 
taken into heparin (5 IU/ml preservative free, Paynes 
and Byrne, Greenford, Middlesex). Neutrophils were 
isolated by dextran sedimentation, centrifugation 
through Ficoll/sodium metrizoate, and hypotonic 
lysis of residual erythrocytes [ 131. The cells were 
resuspended in 20 ml Krebs-Ringers phosphate 
buffer containing 5 IU heparinlml. The purity of 
the neutrophils was >95% in cells obtained from 
the normal controls. Those from the patients were 
contaminated with eosinophils [9] which constituted 
9,15,11 and 5% of the cells in patients number l-4, 
respectively. 
111 
Volume 110, number I FEBS LETTERS January 1980 
2.3. Spectroscopy 
A sensitive split-beam spectrophotometer [14] 
was used. Reduced-oxidised spectra were recorded 
after the addition of a few crumbs of dithionite to 
one of the cuvettes, each of which contained 2.5 ml 
cell suspension. The protein concentration was esti- 
mated in the unreduced samples by the method 
in [15]. 
The effect of stimulation of the cells with PMA 
was studied after the addition of 10 pg PMA in 10 ~1 
dimethyl sulphoxide to 2.5 ml cell suspension after 
both the test and reference cells had been gassed 
with argon [5]. In some studies superoxide dismutase 
(SOD, 100 E_cg 2950 IU/mg, Sigma, from bovine 
erythrocytes) was added to both the reference and 
the test cuvette before the addition of PMA. 
The effect of an O;-- generating system on the 
spectra of intact cells was examined by the addition 
of xanthine oxidase (10 ~1 13.2 IU/ml Sigma, prepared 
from buttermilk) to aerobic cell suspensions in both 
cuvettes in the presence of hypoxanthine (10” M, 
Sigma) in the test cuvette. The generation of O;- by 
this system was tested by the addition of cytochrome c 
(0.15 X 10m3 M, from horse heart, type III, Sigma) to 
the cell suspensions in both cuvettes, in the presence 
and absence of SOD (100 Erg) and found to be 
12.5 ~mol~min taking e = 21 .I Me3. cm-’ for cyto- 
chrome c at 550 nm [16]. 
3. Results 
Reduced-oxidised spectra of intact cells from 
normal subjects (fig.1) clearly demonstrate the 
(Y, /3 and y (or Soret) absorption bands of a cyto- 
chrome b, with minimal interference by myeloper- 
oxidase or eosinophil peroxidase 191. Similar spectra 
were observed with cells from the two female 
patients (1,2). The spectra obtained with cells from 
the male patients were markedly different. Both these 
patients had a broad peak of absorbance with maximal 
absorbance at 43 1 and 435 nm in patients 3 and 4, 
respectively, without evidence of the (11 and 8 peaks of 
a cytochrome b. No evidence of the cytochrome b 
was produced by oxidation of the reference cell with 
potassium ferricyanide. 
Phorbol stimulation resulted in the reduction of 
the cytochrome b of the control cells as in fig.2 of 
[s]. However, in none of the patients with CGD was 
the spectrum of the reduced cytochrome b observed 
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(fig.2). In these patients the major changes were the 
development of troughs at -422 and 444 nm with 
broad peaks at -433 and 463 nm. 
The addition of SOD did not inhibit the PMA- 
induced reduction of the cytochrome b in normal 
cells, and the xanthine/xanthine oxidase O,- 
generating system failed to reduce the cytochrome b 
in neutrophils from the normal controls. 
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Fig.1. Dithionite difference spectra of intact neutrophils from 
4 normal subjects (A-D), two female patients (I ,2) and two 
male patients (3,4) with Chrome ~ranulomatous Disease. The 
peaks of the Soret bands were at 428-429 nm for the normal 
subjects and female patients, 431 nm for patient 3 and 
43.5 nm for patient 4. The integrated areas under the peaks 
in the region of 430 nm have ‘Jeen normalised to 1 mg 
protein/ml, or proportions thereof. The original protein con- 
centrations are shown in fig.2. Absorbance scale marker = 0.008 
absorbance units. 
Volume 110, number 1 FEBS LETTERS January 1980 
Protein 
(pg/mlI 
910 
510 
470 
800 
274 
4;o 4;o ;oo Al 6du 
.l(nm) 
Fig.2. Difference spectra of neutrophils stimulated with 
phorbol my&ate acetate compared with unstimulated cells. 
Spectra were run under anaerobic conditions 3 min after 
stimulation. Symbols refer to the same cell preparations as do 
those in tig.1. Absorbance scale marker = 0.008 absorbance 
units. The protein concentration of the celJ suspensions has 
been measured as an index of the concentration of cells. 
4. Discussion 
These results indicate that neutrophils from 
patients with CGD, unlike controls, fail to reduce a 
plasma membrane-associated cytochrome b after 
stimulation of these cells with PMA. In the two male 
patients, failure of reduction of this cytochrome b 
appears to be attributable to the absence or primary 
abnormality of this molecule, whereas the cells from 
the female patients failed to reduce this cyto- 
chrome b, although a normal cytochrome b spectrum 
was found upon reduction with dithionite. We have 
proposed that the microbicidal oxidase system con- 
sists of a number of components which are integrated 
into a complex electron-transport chain [9]. In this 
case the failure of reduction of the cytochrome b in 
the cells of the female patients could be due to the 
absence of a proximal component of this electron 
transport chain, or to a defect in the mechanisms 
which activate or co-ordinate the system. 
A possible explanation for the failure of the reduc- 
tion of the cytochrome b in the patients with CGD 
was that this reduction is mediated by, rather than 
being responsible for, the production of superoxide. 
This does not appear to be the case because: phor- 
bol stimulation was conducted under anaerobic con- 
ditions, although it is difficult to ensure complex 
anaerobiosis; the addition of superoxide dismutase 
did not inhibit cytochrome b reduction; and the 
addition of an O;- generating system to intact cells 
failed to reduce this cytochrome. 
The reduction of intact, rather than disrupted, 
cells with dithionite greatly improves the spectroscopic 
demonstration of the cytochrome b because this 
reducing agent penetrates membranes slowly [ 171, 
and thus it reduces the cytochrome b which is in the 
plasma membranes [2,3] more readily than compo- 
nents within the cytoplasmic granules. The major 
contribution of myeloperoxidase and eosinophil per- 
oxidase to the spectral changes observed in reduced- 
oxidised spectra [9] can be avoided with this techni- 
que. Under these conditions we have observed broad 
absorption bands with peaks in the region of 
430436 nm in both male patients with CGD. This 
could be due to contaminating haemoglobin, which 
also absorbs in this region, but we have found that 
the spectral changes due to haemoglobin are different 
from those observed in these patients. The spectral 
changes in this region could indicate the presence of 
another redox compound. Similarly, failure of the 
normal reduction of the Soret band of the cyto- 
chrome b upon stimulation with PMA, permits a 
variety of spectral changes at 400-470 nm to be 
observed in cells from patients with CGD, which 
would be obscured in cells from controls. These 
spectral changes could result from redox changes in 
proximal components of an electron transport chain; 
e.g., the broad trough at -444 nm would be con- 
sistent with reduction of a flavoprotein [ 181. 
Failure of reduction of the cytochrome b in 
neutrophils from patients with CGD after stimulation 
with PMA, despite the demonstration of this mole- 
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cule in the cells from two of them, is further evidence 
that this cytochrome b is a component of the normal 
microbicidal oxidase system. Dysfunction of complex 
electron-transpo~ systems as a whole due to different 
abnormalities of individual components is well known 
in bacterial mutants [ 191. 
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